ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC

Immunotherapy by immune checkpoint inhibitors (ICIs) has showed outstanding efficacy in the treatment of advanced non-small cell lung cancer (NSCLC). The combination of immunotherapy with anti-angiogenic therapy exhibited enhanced efficacy in multiline treatment. However, the potential biomarkers fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yao, Li, Xiaobin, Liu, Guifeng, Chen, Shifu, Xu, Mingyan, Song, Lele, Wang, Yina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509428/
https://www.ncbi.nlm.nih.gov/pubmed/33014846
http://dx.doi.org/10.3389/fonc.2020.01706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509428/
https://www.ncbi.nlm.nih.gov/pubmed/33014846
http://dx.doi.org/10.3389/fonc.2020.01706

Ejemplares similares